Glycine

HRas proto-oncogene, GTPase ; Homo sapiens







17 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 27684555 Single Synonymous Mutations in KRAS Cause Transformed Phenotypes in NIH3T3 Cells. 2016 1
2 25367099 Behavioral phenotype in Costello syndrome with atypical mutation: a case report. 2015 Jan 1
3 23335589 Functional analysis of a duplication (p.E63_D69dup) in the switch II region of HRAS: new aspects of the molecular pathogenesis underlying Costello syndrome. 2013 Apr 15 4
4 22821884 A novel HRAS substitution (c.266C>G; p.S89C) resulting in decreased downstream signaling suggests a new dimension of RAS pathway dysregulation in human development. 2012 Sep 2
5 16835863 Paternal bias in parental origin of HRAS mutations in Costello syndrome. 2006 Aug 1
6 10463479 H-ras and K-ras gene mutations in primary human soft tissue sarcoma: concomitant mutations of the ras genes. 1999 Aug 1
7 9324018 H-ras oncogene point mutations in arthritic synovium. 1997 Sep 1
8 9048488 A PCR-RFLP method for the detection of activated H-ras oncogene with a point mutation at codon 12 and 61. 1996 Dec 1
9 7586199 Mutagenicity of a unique 8-oxoguanine in a human Ha-ras sequence in mammalian cells. 1995 Nov 1
10 7628866 Molecular events underlying schistosomiasis-related bladder cancer. 1995 Jul 28 2
11 7880841 Mutagenesis of the H-ras p21 at glycine-60 residue disrupts GTP-induced conformational change. 1995 Mar 14 3
12 7961880 Regulation of cAMP-mediated gene transcription by wild type and mutated G-protein alpha subunits. Inhibition of adenylyl cyclase activity by muscarinic receptor-activated and constitutively activated G(o) alpha. 1994 Nov 18 2
13 7902340 Screening of human bladder tumors and urine sediments for the presence of H-ras mutations. 1993 Nov 11 1
14 8338834 An NMR comparison of the changes produced by different guanosine 5'-triphosphate analogs in wild-type and oncogenic mutant p21ras. 1993 Jul 27 1
15 1312542 Ras mutations in human pituitary tumors. 1992 Apr 1
16 2471068 H-ras mutants lacking the epitope for the neutralizing monoclonal antibody Y13-259 show decreased biological activity and are deficient in GTPase-activating protein interaction. 1989 Apr 1
17 6577419 Prediction of the three-dimensional structure of the transforming region of the EJ/T24 human bladder oncogene product and its normal cellular homologue. 1983 Sep 1